Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WASYLYK B")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 59

  • Page / 3

Export

Selection :

  • and

TRANSCRIPTION BY EUKAYOTIC RNA POLYMERASES A AND B OF CHROMATIN ASSEMBLED IN VITROWASYLYK B; CHAMBON P.1979; EUROP. J. BIOCHEM.; DEU; DA. 1979; VOL. 98; NO 2; PP. 317-327; BIBL. 56 REF.Article

Enhancers and transcription factors in the control of gene expressionWASYLYK, B.Biochimica et biophysica acta. 1988, Vol 951, Num 1, pp 17-35, issn 0006-3002Article

A T TO A BASE SUBSTITUTION AND SMALL DELETIONS IN THE CONALBUMIN TATA BOX DRASTICALLY DECREASE SPECIFIC IN VITRO TRANSCRIPTIONWASYLYK B; CHAMBON P.1981; NUCLEIC ACIDS RES.; ISSN 0305-1048; GBR; DA. 1981; VOL. 9; NO 8; PP. 1813-1824; BIBL. 31 REF.Article

STUDIES ON THE MECHANISM OF TRANSCRIPTION OF NUCLEOSOMAL COMPLEXESWASYLYK B; CHAMBON P.1980; EUROP. J. BIOCHEM.; DEU; DA. 1980; VOL. 103; NO 2; PP. 219-226; BIBL. 26 REF.Article

PREFERENTIAL IN VITRO ASSEMBLY OF NUCLEOSOME CORES ON SOME AT-RICH REGIONS OF SV40 DNAWASYLYK B; OUDET P; CHAMBON P et al.1979; NUCLEIC ACIDS RES.; GBR; DA. 1979; VOL. 7; NO 3; PP. 705-713; BIBL. 21 REF.Article

Oncogenic conversion of Ets affects redox regulation in-vivo and in-vitroWASYLYK, C; WASYLYK, B.Nucleic acids research. 1993, Vol 21, Num 3, pp 523-529, issn 0305-1048Article

EFFECT OF HISTONE ACETYLATION ON STRUCTURE AND IN VITRO TRANSCRIPTION OF CHROMATINMATHIS DJ; OUDET P; WASYLYK B et al.1978; NUCLEIC ACIDS RES.; GBR; DA. 1978; VOL. 5; NO 10; PP. 3523-3547; BIBL. 33 REF.Article

Transcription elements and factors of RNA polymerase B promoters of higher eukaryotesWASYLYK, B; YANIV, M.CRC critical reviews in biochemistry. 1988, Vol 23, Num 2, pp 77-120, issn 0045-6411Article

Oncogenic conversion alters the transcriptional properties of etsWASYLYK, C; WASYLYK, B.Cell growth and differentiation. 1992, Vol 3, Num 9, pp 617-625, issn 1044-9523Article

The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cellsWASYLYK, C; WASYLYK, B.EMBO journal (Print). 1986, Vol 5, Num 3, pp 553-560, issn 0261-4189Article

The MLV and SV40 enhancers have a similar pattern of transcriptional activationAUGEREAU, P; WASYLYK, B.Nucleic acids research. 1984, Vol 12, Num 23, pp 8801-8818, issn 0305-1048Article

TRANSCRIPTION OF IN VITRO ASSEMBLED CHROMATIN BY ESCHERICHIA COLI RNA POLYMERASEWASYLYK B; THEVENIN G; OUDET P et al.1979; J. MOLEC. BIOL.; GBR; DA. 1979; VOL. 128; NO 3; PP. 411-440; BIBL. 2 P.Article

The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sitesGUTMAN, A; WASYLYK, B.EMBO journal (Print). 1990, Vol 9, Num 7, pp 2241-2246, issn 0261-4189, 6 p.Article

SPECIFIC IN VITRO INITIATION OF TRANSCRIPTION ON CONALBUMIN AND OVALBUMIN GENES AND COMPARISON WITH ADENOVIRUS-2 EARLY AND LATE GENESWASYLYK B; KEDINGER C; CORDEN J et al.1980; NATURE; GBR; DA. 1980; VOL. 285; NO 5764; PP. 367-373; BIBL. 45 REF.Article

The Ets family of transcription factorsWASYLYK, B; HAHN, S. L; GIOVANE, A et al.European journal of biochemistry (Print). 1993, Vol 211, Num 1-2, pp 7-18, issn 0014-2956Article

Transforming but not immortalizing oncogenes activate the transcription factor PEA1WASYLYK, C; IMLER, J. L; WASYLYK, B et al.EMBO journal (Print). 1988, Vol 7, Num 8, pp 2475-2483, issn 0261-4189Article

Mutational analysis of the contribution of sequence motifs within IgH enhancer to tissue specific transcriptional activationPEREZ-MUTUL, J; MACCHI, M; WASYLYK, B et al.Nucleic acids research. 1988, Vol 16, Num 13, pp 6085-6096, issn 0305-1048Article

The ternary complex factor Net/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1αGROSS, C; DUBOIS-POT, H; WASYLYK, B et al.Oncogene (Basingstoke). 2008, Vol 27, Num 9, pp 1333-1341, issn 0950-9232, 9 p.Article

The contribution of the RING finger domain of MDM2 to cell cycle progressionARGENTINI, M; BARBOULE, N; WASYLYK, B et al.Oncogene (Basingstoke). 2000, Vol 19, Num 34, pp 3849-3857, issn 0950-9232Article

Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzymeHAHN, S. L; CRIQUI, P; WASYLYK, B et al.Oncogene (Basingstoke). 1997, Vol 15, Num 12, pp 1489-1495, issn 0950-9232Article

Characterization of the human CD4 gene promoter : transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteinsSALMON, P; GIOVANE, A; WASYLYK, B et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 16, pp 7739-7743, issn 0027-8424Article

Repression by jun of the polyoma-virus enhancer overrides activation in a cell specific mannerSCHNEIKERT, J; IMLER, J.-L; WASYLYK, B et al.Nucleic acids research. 1991, Vol 19, Num 4, pp 783-787, issn 0305-1048, 5 p.Article

Two independant activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene familySCHNEIKERT, J; LUTZ, Y; WASYLYK, B et al.Oncogene (Basingstoke). 1992, Vol 7, Num 2, pp 249-256, issn 0950-9232Article

Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53SENGUPTA, S; RALHAN, R; WASYLYK, B et al.Oncogene (Basingstoke). 2000, Vol 19, Num 3, pp 337-350, issn 0950-9232Article

A novel modulator domain of Ets transcription factorsWASYLYK, C; KERCKAERT, J.-P; WASYLYK, B et al.Genes & development. 1992, Vol 6, Num 6, pp 965-974, issn 0890-9369Article

  • Page / 3